(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-iuM tetrafluoroborate 97%
![]() |
- $408 - $1860
- Product name: (5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-iuM tetrafluoroborate 97%
- CAS: 950842-71-4
- MF: C26H26BF4N3O
- MW: 483.32
- EINECS:
- MDL Number:
- Synonyms:(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-iuM tetrafluoroborate 97%;(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate;(5R,6S)-5,6-diphenyl-2-(2,4,6-trimethylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-4-ium;(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-;8H-1,2,4-Triazolo[3,4-c][1,4]oxazinium, 5,6-dihydro-5,6-diphenyl-2-(2,4,6-trimethylphenyl)-, (5R,6S)-, tetrafluoroborate(1-) (1:1)
2 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 100mg
- 500mg
- ManufacturerSigma-Aldrich
- Product number708542
- Product description(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate 97%
- Packaging100mg
- Price$408
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product number708542
- Product description(5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate 97%
- Packaging500mg
- Price$1860
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | 708542 | (5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate 97% | 100mg | $408 | 2024-03-01 | Buy |
Sigma-Aldrich | 708542 | (5R,6S)-2-Mesityl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate 97% | 500mg | $1860 | 2023-06-20 | Buy |
Properties
Melting point :187-193°C
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|